GlaxoSmithKline Cash from Operations TTM:
7.331B for March 31, 2013GlaxoSmithKline Historical Cash from Operations TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 7.331B |
| Dec. 31, 2012 | 7.051B |
| Sept. 30, 2012 | 7.237B |
| June 30, 2012 | 10.26B |
| March 31, 2012 | 9.670B |
| Dec. 31, 2011 | 9.635B |
| Sept. 30, 2011 | 8.503B |
| June 30, 2011 | 7.796B |
| March 31, 2011 | 8.918B |
| Dec. 31, 2010 | 10.54B |
| Sept. 30, 2010 | 12.12B |
| June 30, 2010 | 13.19B |
| March 31, 2010 | 13.33B |
| Dec. 31, 2009 | 12.61B |
| Sept. 30, 2009 | 10.21B |
| June 30, 2009 | 9.890B |
| March 31, 2009 | 9.306B |
| Dec. 31, 2008 | 10.42B |
| Sept. 30, 2008 | 11.71B |
| June 30, 2008 | 12.76B |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
About Cash From Operations (TTM)
GSK Cash from Operations TTM Benchmarks
| Companies | |
|---|---|
| Merck | 10.02B |
| AstraZeneca | 7.606B |
| Eli Lilly and Company | 4.832B |
GSK Cash from Operations TTM Rankings
| Overall |
99th percentile 78 of 8005 |
| Sector |
98th percentile 7 of 686 in Healthcare |
| Industry |
89th percentile 6 of 55 in Drug Manufacturers - Major |
GSK Cash from Operations TTM Range, Past 5 Years
| Minimum | 7.051B | Dec 2012 |
| Maximum | 13.33B | Mar 2010 |
| Average | 10.12B |
